The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: Discuss the danger inherent in nondisclosure of complementary and alternative medicine (CAM) use due to the potential for herb- or vitamin-drug interactions with conventional treatment.Explain the need for greater patient-doctor communication about CAM use in oncology settings in order to maintain patient safety and wellbeing. CME This article is available for continuing medical education credit at CME.TheOncologist.com Objective.: To explore the nondisclosure of complementary and alternative medicine (CAM) use among cancer patients, including reasons for and outcomes from nondisclosure of CAM use, within the context of patient-doctor communication. Method.: A systematic review was conducted exploring investigations surrounding the communication of CAM use for patients with cancer published until August 2011. Results.: A total of 21 studies were located, which reported a prevalence of CAM use among patients with cancer ranging between 11% and 95%; of these patients, 20% to 77% did not disclose their CAM use. The main reasons for nondisclosure were the doctor's lack of inquiry; patient's anticipation of the doctor's disapproval, disinterest, or inability to help; and patient's perception that disclosure of CAM use is irrelevant to their conventional care. There is some evidence to suggest that patient-doctor communication about the use of CAM was associated with an enhanced patient-doctor relationship and higher patient satisfaction. Conclusions.: Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998) · JAMA · doi:10.1001/jama.280.18.1569 · Cited by 6,658
Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields
Kmet, L. M., Cook, L. S., & Lee, R. C. (2004) · University of Alberta Library · doi:10.7939/r37m04f16 · Cited by 1,682
Doctor-patient communication: a review.
Ha, J. F., & Longnecker, N. E. (2010) · PubMed · Cited by 1,347
Use of complementary and alternative medicine in cancer patients: a European survey
Molassiotis, A., Fernadez-Ortega, P., Pud, D., Ozden, G., Scott, J. A., Panteli, V., Margulies, A., Browall, M., Magri, M., Selvekerova, S., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi110 · Cited by 1,136
Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., & Singletary, S. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2505 · Cited by 1,022
Complementary and alternative medicine: use and disclosure in radiation oncology community practice
Rausch, S. M., Winegardner, F., Kruk, K. M., Phatak, V., Wahner-Roedler, D. L., Bauer, B., & Vincent, A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0846-5 · Cited by 813
Use of Alternative Medicine by Women with Early-Stage Breast Cancer
Burstein, H. J., Gelber, S., Guadagnoli, E., & Weeks, J. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402206 · Cited by 634
Boon, H., Stewart, M., Kennard, M. A., Gray, R., Sawka, C., Brown, J. B., McWilliam, C., Gavin, A., Baron, R. A., Aaron, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2515 · Cited by 439
Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan
Hyodo, I., Amano, N., Eguchi, K., Narabayashi, M., Imanishi, J., Hirai, M., Nakano, T., & Takashima, S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.126 · Cited by 346
Verhoef, M. J., Balneaves, L. G., Boon, H. S., & Vroegindewey, A. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735405282361 · Cited by 306
Cited by
Johnson, S. B., Park, H. S., Gross, C. P., & Yu, J. B. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2487 · Cited by 325
Use of Alternative Medicine for Cancer and Its Impact on Survival
Johnson, S. B., Park, H. S., Gross, C. P., & Yu, J. B. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx145 · Cited by 322
Tocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71
Metadata
- Authors
- Davis, E. L., Oh, B., Butow, P. N., Mullan, B. A., & Clarke, S.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-29
- Volume
- 17
- Issue
- 11
- Pages
- 1475-1481
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2147496620
- Cited by
- 346
- References
- 39
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review. https://app.cochat.ai/papers/10.1634/theoncologist.2012-0223
- The paper
- Davis, E. L., Oh, B., Butow, P. N., Mullan, B. A., & Clarke, S. (2012). Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review. The Oncologist. https://doi.org/10.1634/theoncologist.2012-0223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.